Literature DB >> 730368

Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants.

N Hasegawa, C L San Clemente.   

Abstract

Coagulase-negative and deoxyribonuclease-negative mutants were isolated from Staphylococcus aureus BB by treatment with N-methyl-N'-nitro-N-nitrosoguanidine. Comparison of virulence (50% lethal dose) to mice of these six mutant strains and S. aureus BB was determined by both intravenous and intraperitoneal routes. The ratios of the 50% lethal dose of coagulase-negative mutants to that of the parental strain S. aureus BB ranged from 201 to 403 for intravenous infection and 30.7 to 52.7 for intraperitoneal infection. The virulence of deoxyribonuclease-negative mutants was essentially the same as that of S. aureus BB. When mice were immunized subcutaneously with live S. aureus BB or its deoxyribonuclease-negative mutants, the resulting protection against the intravenous challenge of S. aureus BB was remarkable. The ratios of the 50% lethal dose for the mice that were immunized by these strains to that for the untreated mice extended from 40.1 to 60.6 for intravenous infection and 6.61 to 11.5 for the intraperitoneal route. However, no effect against S. aureus BB challenge was shown in the mice that were immunized with coagulase-negative mutants.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730368      PMCID: PMC422180          DOI: 10.1128/iai.22.2.473-479.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  What is a Staphylococcus?

Authors:  J E BLAIR
Journal:  Bacteriol Rev       Date:  1962-12

2.  Staphylococcal leucocidins.

Authors:  G P GLADSTONE; W E VAN HEYNINGEN
Journal:  Br J Exp Pathol       Date:  1957-04

3.  Characteristics of coagulase positive and coagulase negative staphylococci in serum-soft agar.

Authors:  R A FINKELSTEIN; S E SULKIN
Journal:  J Bacteriol       Date:  1958-03       Impact factor: 3.490

4.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

5.  Significance of protein a production by staphylococci.

Authors:  A Forsgren
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

6.  A note on some points of calculation method of LD50 by Reed and Muench.

Authors:  M MATUMOTO
Journal:  Jpn J Exp Med       Date:  1949-09

7.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

8.  Experimental staphylococcal mastitis in the mouse: the effect of inoculating different strains into separate glands of the same mouse.

Authors:  J C Anderson
Journal:  J Comp Pathol       Date:  1974-01       Impact factor: 1.311

9.  [Studies on a unique strain of Staphylococcus showing high virulence for mice after intraperitoneal inoculation. 1. Its morphological and biological properties].

Authors:  K Iwata; T Eda
Journal:  Nihon Saikingaku Zasshi       Date:  1968-03

10.  Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

View more
  8 in total

1.  Dabigatran inhibits Staphylococcus aureus coagulase activity.

Authors:  Thomas Vanassche; Jan Verhaegen; Willy E Peetermans; Marc F Hoylaerts; Peter Verhamme
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

Review 2.  Virulence factors among gram-positive bacteria in experimental endocarditis.

Authors:  L M Baddour
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

3.  Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models.

Authors:  W R Schwan; S N Coulter; E Y Ng; M H Langhorne; H D Ritchie; L L Brody; S Westbrock-Wadman; A S Bayer; K R Folger; C K Stover
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.

Authors:  T Sawai; K Tomono; K Yanagihara; Y Yamamoto; M Kaku; Y Hirakata; H Koga; T Tashiro; S Kohno
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning.

Authors:  P Jonsson; M Lindberg; I Haraldsson; T Wadström
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant.

Authors:  C Bogni; M Segura; J Giraudo; A Giraudo; A Calzolari; R Nagel
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

7.  Effect of highly purified coagulase and culture filtrate on virulence and immunity of a coagulase-negative mutant of staphylococcus aureus BB.

Authors:  N Hasegawa; I Kondo; S Hoshina; K Kurosaka; H Igarashi
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Quercetin protects rats from catheter-related Staphylococcus aureus infections by inhibiting coagulase activity.

Authors:  Lin Wang; BangBang Li; Xiaosa Si; Xingyuan Liu; Xuming Deng; Xiaodi Niu; Yingli Jin; Dacheng Wang; Jianfeng Wang
Journal:  J Cell Mol Med       Date:  2019-05-15       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.